The case for intraocular delivery of PPAR agonists in the treatment of diabetic retinopathy
<p>Abstract</p> <p>Background</p> <p>Systemic therapeutics targeting the peroxisome proliferator-activated receptors have been found to be beneficial in the treatment of diabetic retinopathy. In this paper, we provide a rationale for the use of these therapeutics as int...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-09-01
|
| Series: | BMC Ophthalmology |
| Subjects: | |
| Online Access: | http://www.biomedcentral.com/1471-2415/12/46 |